Risk assessment strategies as nanomaterials transition into commercial applications

Commercial applications of nanomaterials are rapidly emerging in the marketplace. The environmental and human health risks of many nanomaterials remain unknown, and prioritizing how to efficiently assess their risks is essential. As nanomaterials are incorporated into a broader range of commercial products, their potential for environmental release and human exposure not only increases, but also becomes more difficult to model accurately. Emphasis may first be placed on estimating potential environmental exposure based on pertinent physical properties of the nanomaterials. Given that the greatest potential for global environmental impacts results from nanomaterials that are both persistent and toxic, this paper advocates screening first for persistence since it is easier to assess than toxicity. For materials that show potential for persistence, a higher burden of proof of their non-toxicity is suggested before they enter the commercial marketplace whereas a lower burden of proof may be acceptable for nanomaterials that are less persistent.